Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.

Schuster NM, Wallace MS, Marcotte TD, Buse DC, Lee E, Liu L, Sexton M

Open source

DOI
10.1111/head.70025
Published
2026 Feb
Container
Headache
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/head.70025,
  title = {Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.},
  author = {Schuster NM and Wallace MS and Marcotte TD and Buse DC and Lee E and Liu L and Sexton M},
  year = {2026},
  journal = {Headache},
  doi = {10.1111/head.70025},
  url = {https://doi.org/10.1111/head.70025}
}

RIS

TY  - JOUR
TI  - Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.
AU  - Schuster NM
AU  - Wallace MS
AU  - Marcotte TD
AU  - Buse DC
AU  - Lee E
AU  - Liu L
AU  - Sexton M
PY  - 2026
JO  - Headache
DO  - 10.1111/head.70025
UR  - https://doi.org/10.1111/head.70025
ER  - 

APA

NM, S., MS, W., TD, M., DC, B., E, L., L, L., & M, S. (2026). Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.. Headache. https://doi.org/10.1111/head.70025

Source records